Tien Lee, Aardvark Therapeutics CEO
January 24, 2025 03:36 AM ESTUpdated 06:20 AM
Financing
Startups

Obe­si­ty biotech Aard­vark files for IPO to ad­vance oral, hunger-sup­press­ing drug

Kyle LaHucik

Senior Reporter

Aard­vark Ther­a­peu­tics filed for an IPO Thurs­day night, mak­ing it the sixth biotech in line this year for a po­ten­tial list­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

No­vo Nordisk’s amy­cretin prompts 22% weight loss in ear­ly obe­si­ty tri­al

Mod­er­na in­for­ma­tion chief to re­tire next month; Pharm­ing looks to Flag­ship for first new CEO since 2008

ALX On­col­o­gy to make case for ac­cel­er­at­ed ap­proval with new evor­pacept da­ta in gas­tric can­cer

As an­oth­er Trump term gets un­der­way, phar­ma ad­vi­sors get com­fort­able with un­cer­tain­ty

Pur­due, Sack­lers reach new $7.4B opi­oid set­tle­ment af­ter SCO­TUS re­jec­tion

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times